The Book of Eli became one of the most unique post-apocalyptic films with its mix of survival, faith, and brutal violence. A sequel could explore what happened after Eli’s mission and how the world ...

Pharmaceutical giant Eli Lilly plans to buy a biotechnology company in Bothell for $1.5 billion. The acquisition of Curevo Vaccine, which develops vaccines for shingles and chickenpox, was announced ...

The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr virus and other pathogens. By Rebecca Robbins Eli Lilly said on Tuesday that ...

Rabbi Eli Schlanger, killed in the Bondi Beach massacre, reflected on the destructive power of words and deeds for a forthcoming book. Editor’s Note: The following is an excerpt of Rabbi Eli Schlanger ...

In a clinical trial, the new weight-loss medication retatrutide led to "clinically meaningful weight reduction," with the highest dose linked to a 30% reduction in average body weight Cara Lynn Shultz ...

It took 22 years, but Eli Manning has finally revealed the details behind one of the biggest draft controversies in NFL history. Back in 2004, the Chargers made Manning the No. 1 overall pick in the ...

It’s clear before the curtain rises – before you’ve even set foot in the theatre – that The Guy Who Didn’t Like Musicals is about more than the sum of its parts. Several audience members are in ...

In 1876, Alexander Graham Bell received the patent for the telephone, William McKinley was elected president of the United States and Colorado became the country's 38th state. That same year, on May ...

Eli Lilly trades at $948.45 as of writing. Our 24/7 Wall St. price target is $1,085 over the next 12 months, implying roughly 14.3% upside. The recommendation is buy with a confidence level of 70%.

Rob Gregson breaks down why rookie offensive weapon Eli Heidenreich could carve out a role with the Pittsburgh Steelers and potentially become the next versatile playmaker in the offense. From special ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...

There wasn't many questions surrounding the Philadelphia Eagles at tight end heading into the NFL Draft -- at least for the 2026 season. The Eagles did the best they could to run it back at tight end.